This is the text extract for 2010-11 Schedule Dispatch , browse documents here.

---

18 October 2010 November 2010 Pharmaceutical Schedule Dispatch

This document is provided to pharmacists as an early notification of the changes to be announced in the November 2010 Update to the Pharmaceutical Schedule. Please notify PHARMAC (0800 66 00 50) to change or remove your contact details. New listings · Acetylcysteine (Acetadote) inj 200 mg per ml, 30 ml – Retail pharmacy-Specialist (p’code 2360233) · Bacillus calmette-guerin (BCG) vaccine inj 2-8 x 100 million CFU – PCT only – Specialist – Subsidised only for bladder cancer (p’code 799629) · Captopril (m-Captopril) tab 12.5 mg (p’code 2356554), 25 mg (p’code 2356562) and 50 mg (p’code 2356570) · Darunavir (Prezista) tab 300 mg (p’code 2314606) and 400 mg (p’code 2375680) – Special Authority – Retail pharmacy · Donepezil hydrochloride (Donepezil-Rex) tab 5 mg (p’code 2349159) and 10 mg (p’code 2349140) · Etanercept (Enbrel) inj 50 mg autoinjector – Special Authority – Retail pharmacy (p’code 2375729) · Etravirine (Intelence) tab 100 mg – Special Authority – Retail pharmacy (p’code 2375672) · Insulin pen needles (B-D Micro-Fine) 32 g x 4 mm – maximum of 100 dev per prescription (p’code 2375737) · Levetiracetam (Levetiracetam-Rex) tab 250 mg (p’code 2349183), 500 mg (p’code 2349175) and 750 mg (p’code 2349167) · Selegiline hydrochloride (Apo-Selegiline) tab 5 mg – Section 29 (p’code 2374420) · Sunitinib (Sutent) cap 12.5 mg (p’code 2243962), 25 mg (p’code 2243970) and 50 mg (p’code 2243989) – Special Authority – Retail pharmacy · Varenicline tartrate (Champix) tab 0.5 mg x 11 and 1 mg x 14, 1 OP (p’code:2375710); tab 1 mg, 28 tab (p’code: 2251612) and 56 tab (p’code 2251604) – Special Authority – Retail pharmacy. Note – the Pharmacode for Champix starter pack will change from 1 November 2010. New Brand Switch Payments · Pharmacy Services (BSF Arrow-Enalapril) brand switch fee (p’code 2375613) – no patient co-payment payable The above Pharmacode corresponds with the first Brand Switch payment listed as part of the 2010 Pharmacy Services Contract. Full details on dispensing Brand Switch payments, along with resources to aid pharmacists in explaining brand switches will be sent to all pharmacies before 1 November. For more information in the meantime, visit: http://www.pharmac.govt.nz/2010/10/17 Changes to restrictions · Sodium chloride (Pharmacia and Multichem) inj 0.9%, 20 ml – removal of Up to 5 inj available on a PSO · Enalapril (Arrow-Enalapril) tab 5 mg, 10 mg and 20 mg – a brand switch fee may be dispensed from 1 November 2010 until 31 January 2011 · Adalimumab (HumiraPen and Humira) inj 40 mg per 0.8 ml prefilled pen and syringe – amended Special Authority criteria · Etanercept (Enbrel) inj 25 mg and 50 mg autoinjector – removal of Retail pharmacySpecialist prescription – amended Special Authority criteria · Venlafaxine (Efexor XR) cap 37.5 mg, 75 mg and 150 mg – amended Special Authority criteria · Levetiracetam tab 250 mg, 500 mg and 750 mg – removal of Special Authority A386623 Page 1 of 2

---

·

Pilocarpine (Isopto Carpine) eye drops 1%, 2% and 4% - removal of Section 29

Decreased subsidy Chemical Presentation Fully subsidised brands Partially subsidised brands

Konsyl-D Mucilax Isogel Normacol Metamucil Mucilax Normacol Plus B-PlexADE MultiADE Apo-Clopidogrel Apo-BComplex ArrowClopidogrel, Plavix Mayne AFT Cromolux

Mucilaginous laxatives

Mucilaginous laxatives Mucilaginous laxatives Mucilaginous laxatives with stimulants Vitamin B Complex Vitamins Clopidogrel

Dry 325 g OP 380 g OP 450 g OP 500 g OP Dry - original flavour, regular texture only 336 g OP Sugar free 275 g OP Dry 200 g OP and 500 g OP Tab, strong, BPC Tab (BPC cap strength) Tab 75 mg

Konsyl-D

Furosemide Ceftriaxone sodium Sodium cromoglycate

Inj 10 mg per ml, 2 ml Inj 500 mg Eye drops 2%

Frusemide-Claris Veracol Rexacrom

Increased subsidy Chemical

Daunorubicin Terbutaline sulphate

Presentation

Inj 2 mg per ml, 10 ml Inj 20 mg for ECP Powder for inhalation, 250 µg per dose, breath activated inhaler

Fully subsidised brands

Pfizer Baxter Bricanyl Turbuhaler

NB. For further details and magnitude of the above subsidy changes, please consult the online version of the Update to the Pharmaceutical Schedule at: www.pharmac.govt.nz/healthpros/Schedule.

New Job Opportunity at PHARMAC – Wellington based PHARMAC is seeking a full-time Schedule Analyst. The role requires a pharmacy background. Key responsibilities are the production of the Schedule & Updates; responding to queries from doctors, pharmacists and patients; collating hospital pharmaceutical utilisation data, project work, building PHARMAC’s relationship with pharmacy, and training health professionals in using the Schedule. For more information see: http://www.pharmac.govt.nz/2010/10/15

A386623 Page 2 of 2